Eli Lilly, Bristol Myers Squibb, Sanofi and Novartis are seeking to block a major hospital trade group from intervening in court cases over their proposed 340B drug rebate models.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback